The #SpinOff company #OnaTherapeutics raises $86.6M Series B funding to advance first-in-class ADCs into clinical development
The global #biopharmaceutical company was launched in 2019 by the #BISTCommunity centre @irbbarcelona.org to address advanced #Cancer
š bist.eu/ona-therapeu...
BIST-Barcelona Institute of Science and Technology
